Contents hide 1 About Pomalidomide 2 Multiple Myeloma 2.1 Low-dose dexamethasone 3 Kaposi Sarcoma 3.1 AIDS-related Kaposi sarcoma (KS) 3.2 KS in adults who are HIV-negative About Pomalidomide Pomalidomide is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. Pomalidomide directly inhibits angiogenesis and myeloma cell growth. This dual effect is central to its activity in myeloma, rather than other pathways such as TNF alpha inhibition, since potent TNF inhibitors including rolipram and pentoxifylline do not inhibit myeloma cell growth or angiogenesis. Upregulation of interferon gamma, IL-2 and IL-10 as well as downregulation of IL-6 have been reported for pomalidomide. These changes may contribute to pomalidomide’s anti-angiogenic and anti-myeloma … Continue reading POMMADX 2 (Pomalidomide)